U.S. Physical Therapy stock trades below EUR 74.00 and Davis joined its board

Published on 10/08/2026 at 10:57 | Editorial responsibility: Rafael Müller, Editor-in-Chief AD HOC NEWS

Q2 revenue rose 8.50 percent to USD 214.06 million. U.S. Physical Therapy stock costs EUR 73.50 on October 8, 2026 after EUR 74.00.

USPH, US90337L1089, Illustration mit AI erstellt.

U.S. Physical Therapy (ISIN US90337L1089) was trading at EUR 73.50 at Lang & Schwarz on October 8, 2026 at 10:43 a.m. CEST, down 0.68 percent versus the prior close of EUR 74.00. The company had appointed Myra Davis to its board effective October 1, 2026, according to Business Wire on September 21, 2026.

Technology expertise joins the board

Davis is executive vice president and chief information innovation officer at Texas Children's Hospital, a role she has held since 2023. Business Wire reported that she has held information technology leadership roles at the hospital since 2003, including chief information officer from 2009 to 2019.

The appointment adds technology and digital transformation experience to a healthcare operator that owns or manages 799 outpatient physical therapy clinics in 45 states, according to the same September 21 company release. The board change therefore broadens the governance profile while the operating case still rests on clinic volumes, reimbursement and labor costs.

Revenue growth meets margin pressure

U.S. Physical Therapy reported USD 214.06 million of revenue in the second quarter of 2026, an 8.50 percent increase from the second quarter of 2025. ScanX also reported adjusted EBITDA of USD 27.00 million, versus USD 26.90 million in the year-earlier quarter.

The comparison is less favorable for profitability: adjusted physical therapy gross margin fell to 19.90 percent from 21.40 percent in the second quarter of 2025, while visits grew 6.60 percent to 1,662,000. The combination points to a clear investor tension, with volume expansion currently outpacing margin improvement.

Analyst target remains above the quote

MarketBeat reported on September 29, 2026 that seven analysts held a Moderate Buy consensus and an average 12-month target of USD 98.25. USPH was last at USD 82.96 on the NYSE on October 7, 2026 at 4:00 p.m. ET, putting the price 15.56 percent below that target.

MarketBeat also said JPMorgan had raised its target from USD 90.00 to USD 95.00 in a September 11, 2026 research note. The target comparisons are in US dollars and are separate from the euro reference quote used for German-market investors.

USPH stays below EUR 74.00

At Lang & Schwarz, U.S. Physical Therapy stock was trading at EUR 73.50 on October 8, 2026 at 10:43 a.m. CEST, down 0.68 percent against the EUR 74.00 prior close dated October 7, 2026. The continuously updated real-time quote of U.S. Physical Therapy stock.